Post-TBI spasticity management includes which of the following approaches?

Post-TBI spasticity management includes which of the following approaches?

• A. Sedation only
• B. Heat therapy
• C. Antidepressants only
• D. Physical therapy; baclofen or tizanidine; botulinum toxin; sometimes surgical interventions

Answer: (D)

Post-TBI spasticity is best managed with a multimodal approach that combines rehabilitation, medications, targeted injections, and, in some cases, surgical options to reduce abnormal muscle tone and improve function. Physical therapy is foundational because it maintains joint range, complements stretching, strengthens supportive muscles, and helps prevent contractures while maximizing functional gains. Medications like baclofen or tizanidine address the neural drive to muscles—baclofen dampens spinal reflexes, and tizanidine reduces excitatory output—providing broader tone reduction. For focal spasticity, botulinum toxin injections offer targeted relief in specific muscles, allowing more effective stretching and motor control in those areas. In more severe or refractory cases, surgical interventions such as tendon lengthening or release, or intrathecal baclofen pumps to deliver medication directly to the spinal cord, may be considered to achieve better function. Other options—sedation alone, heat therapy alone, or antidepressants alone—do not provide the sustained, comprehensive management needed to reduce spasticity and improve function. Heat therapy can offer transient comfort but doesn’t meaningfully modify tone, and sedatives or antidepressants are not primary strategies for long-term spasticity control.

Post-TBI spasticity is best managed with a multimodal approach that combines rehabilitation, medications, targeted injections, and, in some cases, surgical options to reduce abnormal muscle tone and improve function. Physical therapy is foundational because it maintains joint range, complements stretching, strengthens supportive muscles, and helps prevent contractures while maximizing functional gains. Medications like baclofen or tizanidine address the neural drive to muscles—baclofen dampens spinal reflexes, and tizanidine reduces excitatory output—providing broader tone reduction. For focal spasticity, botulinum toxin injections offer targeted relief in specific muscles, allowing more effective stretching and motor control in those areas. In more severe or refractory cases, surgical interventions such as tendon lengthening or release, or intrathecal baclofen pumps to deliver medication directly to the spinal cord, may be considered to achieve better function.

Other options—sedation alone, heat therapy alone, or antidepressants alone—do not provide the sustained, comprehensive management needed to reduce spasticity and improve function. Heat therapy can offer transient comfort but doesn’t meaningfully modify tone, and sedatives or antidepressants are not primary strategies for long-term spasticity control.